Ysios Capital Partners is one of the first independent venture capital firms in Spain providing private equity financing to early- and mid-stage human healthcare and biotechnology companies. They target the entire healthcare and biotechnology industry with special focus on pharmaceuticals, diagnostics and medical devices. They are currently raising the largest venture capital fund in Spain focused on human healthcare innovations.
| Company | Date | Round | Size | Participants |
| Medlumics | 12/11 | Series A | €3.5M | 2 |
| AM-Pharma | 9/11 | Series D | €29.2M | 4 |
| STAT-Diagnostica | 6/11 | Series A | €2M | 1 |
| Sabirmedical | 9/10 | Venture Round | €5M | 2 |
| Cardoz | 9/10 | Series A | kr124M | 4 |
| Cellerix | 1/10 | Series C | $37.7M | 6 |
| BioVex | 11/09 | Series F | $30M | 5 |
| Endosense | 10/09 | Series B | $36M | 7 |
| Cellerix | 9/07 | Series B | €27.2M | 6 |
